Publication | Closed Access
PRECLINICAL AND PHASE 1 CLINICAL SAFETY OF SETARUD (IMODTM), A NOVEL IMMUNOMODULATOR
20
Citations
19
References
2009
Year
Unknown Venue
Translational MedicineAutoimmune DiseaseAllergyA Novel ImmunomodulatorMedicineImmunologyAutoimmunityImmunomodulationImmune FunctionImmunosuppressionImmune SystemImmunotherapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1